BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 24461064)

  • 21. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
    Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
    EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN.
    Elliott PR; Komander D
    FEBS J; 2016 Jan; 283(1):39-53. PubMed ID: 26503766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The E3 ubiquitin ligases HOIP and cIAP1 are recruited to the TNFR2 signaling complex and mediate TNFR2-induced canonical NF-κB signaling.
    Borghi A; Haegman M; Fischer R; Carpentier I; Bertrand MJM; Libert C; Afonina IS; Beyaert R
    Biochem Pharmacol; 2018 Jul; 153():292-298. PubMed ID: 29378181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linear ubiquitin chains: enzymes, mechanisms and biology.
    Rittinger K; Ikeda F
    Open Biol; 2017 Apr; 7(4):. PubMed ID: 28446710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LUBAC-mediated linear ubiquitination in tissue homeostasis and disease.
    Sasaki K; Iwai K
    J Biochem; 2023 Jul; 174(2):99-107. PubMed ID: 37279649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis and regulation of OTULIN-LUBAC interaction.
    Elliott PR; Nielsen SV; Marco-Casanova P; Fiil BK; Keusekotten K; Mailand N; Freund SM; Gyrd-Hansen M; Komander D
    Mol Cell; 2014 May; 54(3):335-48. PubMed ID: 24726323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.
    Shi R; Shi X; Qin D; Tang S; Vermeulen M; Zhang X
    Cell Biosci; 2021 Jul; 11(1):146. PubMed ID: 34315543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death.
    Kupka S; Reichert M; Draber P; Walczak H
    FEBS J; 2016 Jul; 283(14):2626-39. PubMed ID: 26749412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin-dependent and -independent functions of OTULIN in cell fate control and beyond.
    Weinelt N; van Wijk SJL
    Cell Death Differ; 2021 Feb; 28(2):493-504. PubMed ID: 33288901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk Between NDP52 and LUBAC in Innate Immune Responses, Cell Death, and Xenophagy.
    Miyashita H; Oikawa D; Terawaki S; Kabata D; Shintani A; Tokunaga F
    Front Immunol; 2021; 12():635475. PubMed ID: 33815386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.
    Kupka S; De Miguel D; Draber P; Martino L; Surinova S; Rittinger K; Walczak H
    Cell Rep; 2016 Aug; 16(9):2271-80. PubMed ID: 27545878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linear Ubiquitination Mediates EGFR-Induced NF-κB Pathway and Tumor Development.
    Hua F; Hao W; Wang L; Li S
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OTULIN limits cell death and inflammation by deubiquitinating LUBAC.
    Heger K; Wickliffe KE; Ndoja A; Zhang J; Murthy A; Dugger DL; Maltzman A; de Sousa E Melo F; Hung J; Zeng Y; Verschueren E; Kirkpatrick DS; Vucic D; Lee WP; Roose-Girma M; Newman RJ; Warming S; Hsiao YC; Kőműves LG; Webster JD; Newton K; Dixit VM
    Nature; 2018 Jul; 559(7712):120-124. PubMed ID: 29950720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.
    Verhelst K; Carpentier I; Kreike M; Meloni L; Verstrepen L; Kensche T; Dikic I; Beyaert R
    EMBO J; 2012 Oct; 31(19):3845-55. PubMed ID: 23032186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Update on Autoinflammatory Diseases: Relopathies.
    Steiner A; Harapas CR; Masters SL; Davidson S
    Curr Rheumatol Rep; 2018 May; 20(7):39. PubMed ID: 29846841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin.
    Keusekotten K; Elliott PR; Glockner L; Fiil BK; Damgaard RB; Kulathu Y; Wauer T; Hospenthal MK; Gyrd-Hansen M; Krappmann D; Hofmann K; Komander D
    Cell; 2013 Jun; 153(6):1312-26. PubMed ID: 23746843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism underlying IκB kinase activation mediated by the linear ubiquitin chain assembly complex.
    Fujita H; Rahighi S; Akita M; Kato R; Sasaki Y; Wakatsuki S; Iwai K
    Mol Cell Biol; 2014 Apr; 34(7):1322-35. PubMed ID: 24469399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF-κB to the nucleus.
    Wu Z; Berlemann LA; Bader V; Sehr DA; Dawin E; Covallero A; Meschede J; Angersbach L; Showkat C; Michaelis JB; Münch C; Rieger B; Namgaladze D; Herrera MG; Fiesel FC; Springer W; Mendes M; Stepien J; Barkovits K; Marcus K; Sickmann A; Dittmar G; Busch KB; Riedel D; Brini M; Tatzelt J; Cali T; Winklhofer KF
    EMBO J; 2022 Dec; 41(24):e112006. PubMed ID: 36398858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.